Your session is about to expire
← Back to Search
Naloxone for Reproductive Disorders
Study Summary
This trial will test if taking an opioid antagonist improves the function of the hypothalamic-pituitary-gonadal axis in healthy people.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2009 Phase 2 trial • 36 Patients • NCT00586898Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- My testicular volume is more than 15 ml.I haven't taken any prescription meds in the last 2 months, except for allergy meds.I am not pregnant or breastfeeding.I do not have any long-term illnesses.My puberty started and progressed normally.My blood pressure is below 140/90 mm Hg.I have no issues with having my blood drawn.My drug test results were negative.I have not taken oral contraceptives for at least 1 month.I do not have excessive hair growth or severe acne.I am a man with normal sexual function and no history of reproductive issues.
- Group 1: kisspeptin, GnRH, naloxone
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any regulatory approvals for GnRH usage?
"Our team's assessment of GnRH has placed it at a score of 1, indicating that clinical data on its safety and efficacy is quite limited."
Is this experimental research open to elderly participants?
"The cut off for patient enrolment in this clinical trial is between 21 and 40 years old."
Are there any precedents of GnRH being used in a medical experiment?
"Presently, 80 studies on GnRH are underway. Of those in progress, 19 have reached Phase 3 status. Based out of White River Junction, Vermont, the scope of these clinical trials is expansive with 1436 locations offering this treatment regimen."
What is the maximum capacity of participants accepted for this clinical trial?
"Currently, this clinical trial is not actively recruiting patients. It was initially uploaded on the 3rd of June 2022 and its last update occurred on the 29th of June 2022. If you are in search for other medical studies, there are 1 trials seeking participants with reproductive disorders and 80 GnRH related investigations that are enrolling patients as we speak."
Is this research endeavor actively seeking new participants?
"This medical study has closed registration and is no longer seeking patients. It was initially posted on June 3rd, 2022 but as of June 29th it had ceased to accept new participants. However, there are 1 studies looking for individuals with reproductive disorders and 80 trials involving GnRH that are open to enrollment right now."
What type of individuals is this clinical trial specifically targeting?
"This research trial requires 23 individuals aged 21-40 with reproductive disorders to qualify. Additionally, candidates should have experienced a normal puberty and not be taking any medications (except seasonal allergies), engaging in illicit drug use or excessive alcohol consumption (>10 drinks/week). Furthermore, participants must not have had prior medical reactions requiring emergency care and possess an adequate BMI (18.5 - 30 kg/m2) as well as normal blood pressure readings (<140 mmHg systolic & <90 mmHg diastolic)."
Share this study with friends
Copy Link
Messenger